04.12.23 -- Using Demand-Led Supply And Direct-To-Patient Distribution To Navigate Today's Increasingly Complex Studies

Thoroughly planned resupply strategies and carefully calibrated shipment timing are crucial to maintaining clinical supply inventories as drug products enter late-stage development. In this Q&A, Philip Johnston, clinical supply lead, discusses best practices for efficient and timely clinical resupply and how to execute successful supply chain strategies.

Pharmaceutical companies face a number of challenges when sourcing comparator compounds for clinical trials, including addressing product lead times, availability, expiry limitations, safety, or cost. Review how clinical trial sponsors can determine the best strategy to overcome these obstacles.

Successfully sourcing commercial products for comparative studies in an effective and efficient manner often proves far more challenging than assumed. A comprehensive plan should include insight from comparator sourcing and clinical supply management.

Demand-led supply and direct-to-patient distribution are helping address hurdles presented by today’s increasingly complex studies. Safeguarding the integrity of the study drugs through proper handling, and keen quality oversight and ensuring continuity of supply, are critical components.